Relationship	O
between	O
XspI	B:C0752931
Site	B:C1709929
Polymorphisms	I:C1709929
of	O
LDL	B:C1366529
-	I:C1366529
R	I:C1366529
Gene	I:C1366529
and	O
Serum	B:C0021756
IL	I:C0021756
-	I:C0021756
2	I:C0021756
and	O
IL	B:C0085295
-	I:C0085295
10	I:C0085295
in	O
Patients	O
with	O
Hypercholesterolemia	B:C0020443
.	O

Relationship	O
has	O
been	O
identified	O
in	O
sporadic	B:C0243095
reports	I:C0243095
between	O
polymorphisms	O
and	O
hypercholesterolemia	B:C0020443
.	O

However	O
,	O
the	O
relationship	O
between	O
inflammatory	O
cytokines	B:C0079189
and	O
polymorphism	O
of	O
low	B:C1366529
-	I:C1366529
density	I:C1366529
lipoprotein	I:C1366529
receptor	I:C1366529
(	I:C1366529
LDL	I:C1366529
-	I:C1366529
R	I:C1366529
)	I:C1366529
gene	I:C1366529
in	O
hypercholesterolemia	B:C0020443
is	O
unclear	O
.	O

This	O
study	B:C2603343
aimed	O
to	O
explore	O
the	O
relationship	O
and	O
significance	O
between	O
polymorphisms	O
of	O
LDL	B:C1366529
-R	I:C1366529
gene	I:C1366529
and	O
serum	B:C0021756
Interleukin	I:C0021756
-	I:C0021756
2	I:C0021756
(	O
Interleukin	B:C0021756
-	I:C0021756
2	I:C0021756
)	O
,	O
IL	B:C0085295
-	I:C0085295
10	I:C0085295
in	O
patients	O
with	O
hypercholesterolemia	B:C0020443
.	O

PCR	B:C0200930
-	I:C0200930
RFLP	I:C0200930
and	O
direct	B:C0917792
DNA	I:C0917792
sequencing	I:C0917792
assay	I:C0917792
were	O
employed	B:C0557351
to	O
determine	O
polymorphism	O
of	O
LDL	B:C1366529
-	I:C1366529
R	I:C1366529
gene	I:C1366529
in	O
900	O
patients	O
with	O
hypercholesterolemia	B:C0020443
and	O
400	O
healthy	O
cases	O
.	O

ELISA	B:C0014441
was	O
applied	O
to	O
assay	O
serum	O
concentration	O
of	O
Interleukin	B:C0021756
-	I:C0021756
2	I:C0021756
and	O
IL	B:C0085295
-	I:C0085295
10	I:C0085295
.	O

Blood	O
lipid	O
indexes	B:C0600653
were	O
tested	O
in	O
all	O
cases	O
.	O

Compared	O
with	O
the	O
healthy	O
controls	O
,	O
level	O
of	O
Interleukin	B:C0021756
-	I:C0021756
2	I:C0021756
increased	O
significantly	O
,	O
while	O
IL	B:C0085295
-	I:C0085295
10	I:C0085295
decreased	O
significantly	O
(	O
P	O
<	O
0.05	O
)	O
.	O

Correlation	B:C0010101
analysis	I:C0010101
showed	O
that	O
Interleukin	B:C0021756
-	I:C0021756
2	I:C0021756
was	O
positively	O
correlated	O
with	O
total	B:C0543421
cholesterol	I:C0543421
(	O
total	B:C0543421
cholesterol	I:C0543421
)	O
,	O
LDL-c	B:C0023824
,	O
and	O
genotype	O
(	O
r	O
=	O
0.542	O
,	O
0.410	O
,	O
0.598	O
,	O
P	O
<	O
0.05	O
)	O
and	O
negatively	B:C0243095
correlated	O
with	O
HDL	B:C0023822
-c	I:C0023822
(	O
r	O
=	O
-	O
0.352	O
,	O
P	O
<	O
0.05	O
)	O
.	O

Negative	B:C0205160
relationship	O
also	O
was	O
found	O
between	O
total	B:C0543421
cholesterol	I:C0543421
,	O
LDL	B:C0023824
-c	I:C0023824
,	O
genotype	O
,	O
and	O
IL	B:C0085295
-	I:C0085295
10	I:C0085295
(	O
r	O
=	O
-	O
0.452	O
,	O
-0.390	O
,	O
-	O
0.613	O
,	O
P	O
<	O
0.05	O
)	O
,	O
and	O
positive	B:C1446409
correlation	O
between	O
HDL-c	B:C0023822
and	O
IL	B:C0085295
-	I:C0085295
10	I:C0085295
(	O
r	O
=	O
0.398	O
,	O
P	O
<	O
0.05	O
)	O
.	O

Multiple	O
linear	O
regression	O
showed	O
that	O
genotypes	O
and	O
total	B:C0543421
cholesterol	I:C0543421
were	O
independent	O
factors	O
affecting	O
the	O
levels	B:C0022885
of	I:C0022885
IL	I:C0022885
-	I:C0022885
2	I:C0022885
and	O
IL	B:C0022885
-	I:C0022885
10	I:C0022885
(	O
P	O
<	O
0.05	O
)	O
.	O

Interleukin	B:C0021756
-	I:C0021756
2	I:C0021756
and	O
IL	B:C0085295
-	I:C0085295
10	I:C0085295
were	O
related	O
to	O
gene	O
polymorphisms	O
of	O
low	B:C1366529
-	I:C1366529
density	I:C1366529
lipoprotein	I:C1366529
receptor	I:C1366529
,	O
which	O
might	O
be	O
involved	O
in	O
the	O
development	O
and	O
progress	O
of	O
hypercholesterolemia	B:C0020443
.	O

